title: From 'Make in India' to 'Made in India': the saroglitazar story.
authors.affiliation: Additional Professor, Department of Cardiology, All India Institute of Medical Sciences, Delhi, India. Electronic address: ramaaiims@gmail.com.
authors.forename: Sivasubramanian
authors.initials: S
authors.lastname: Ramakrishnan
mesh_terms: D006801:Humans; D007194:India
keywords: Indian pharmaceutical industry; Made in India; PPAR agonists; Saroglitazar
references.citation: Diabetes Technol Ther. 2014 Feb;16(2):63-71
references.pmid: 24138536
references.citation: J Diabetes Sci Technol. 2014 Jan 16;8(1):132-141
references.pmid: 24876549
references.citation: Circ Cardiovasc Qual Outcomes. 2012 Jul 1;5(4):463-71
references.pmid: 22787067
references.citation: Indian Heart J. 2013 Dec;65(6):683-90
references.pmid: 24407538
references.citation: Curr Drug Targets. 2014 Feb;15(2):151-5
references.pmid: 23906191
references.citation: Curr Opin Lipidol. 2013 Jun;24(3):233-8
references.pmid: 23594710
references.citation: Indian Heart J. 2015 Jan-Feb;67(1):23-6
references.pmid: 25820046
references.citation: Antimicrob Agents Chemother. 2012 Oct;56(10):5258-63
references.pmid: 22850522
references.citation: Clin Drug Investig. 2013 Nov;33(11):809-16
references.pmid: 24062180
references.citation: Biochem Pharmacol. 2014 Nov 1;92(1):73-89
references.pmid: 25083916
references.citation: Indian Heart J. 2009 Jul-Aug;61(4):322-7
references.pmid: 20635733
references.citation: Curr Atheroscler Rep. 2013 Jan;15(1):290
references.pmid: 23242605
references.citation: Am J Cardiovasc Drugs. 2011 Aug 1;11(4):227-47
references.pmid: 21675801